1. Home
  2. HWKN vs URGN Comparison

HWKN vs URGN Comparison

Compare HWKN & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

N/A

Current Price

$124.58

Market Cap

2.5B

ML Signal

N/A

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

N/A

Current Price

$43.39

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HWKN
URGN
Founded
1938
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
HWKN
URGN
Price
$124.58
$43.39
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$200.00
$29.29
AVG Volume (30 Days)
108.5K
985.0K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
0.46%
N/A
EPS Growth
N/A
N/A
EPS
1.35
N/A
Revenue
$1,083,696,000.00
$1,128,000.00
Revenue This Year
$12.37
$129.09
Revenue Next Year
$6.30
$70.96
P/E Ratio
$89.09
N/A
Revenue Growth
11.21
N/A
52 Week Low
$116.05
$15.86
52 Week High
$186.15
$50.81

Technical Indicators

Market Signals
Indicator
HWKN
URGN
Relative Strength Index (RSI) 42.90 45.28
Support Level $120.87 $18.25
Resistance Level $156.25 $43.93
Average True Range (ATR) 3.99 1.82
MACD 0.40 -0.90
Stochastic Oscillator 43.87 14.81

Price Performance

Historical Comparison
HWKN
URGN

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The Industrial Solutions segment, provides industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. The water treatment segment, which generates the majority of revenue sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Food and Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Share on Social Networks: